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John Cuomo, the director of chemistry
research atAgriDyne, the products have been
accepted very well by growers, and the com-
pany continues to receive many requests for
the products.
Although the neem seems to have endless
possibilities, there are some disadvantages that
need to be overcome. According to the NRC
study, "the truth is that despite all its proper-
ties and promise, some impediments must be
overcome and many uncertainties clarified
before neem's potential can be fully realized."
For example, neem products sometimes
degrade and lose their pest-control properties
when exposed to sunlight. This has been mit-
igated in some U.S. products by the addition
ofsunscreen. Cuomo said that the AgriDyne
products do not contain sunscreen because it
is not necessary for them to be effective. On a
positive note, he said because of the UV
breakdown and the hydrolysis of the neem
products, they decompose rapidly, preventing
buildup in the environment.
Although there appear to be few adverse
human health effects of neem ingredients,
further toxicity tests need to be conducted.
Toxicity tests on fish and other wildlife also
require investigation. Another disadvantage
ofthe use ofneem insecticides is that theykill
insects bydelayed action, so theyworkslower
than synthetic pesticides. Consumers who
have become accustomed to instant results
may be impatient with the slower action of
neem insecticides. Cuomo said that although
AgriDyne's products are slow-acting, they are
veryeffective ifused for afull season.
Perhaps one of the greatest advantges of
the neem is the fact that its fruits maybe har-
vested without destroying the tree, making
the neem more profitable standing than
felled. As stated in the NRC report, "the use
ofneem products has the merit ofpromoting
agreening ofthe earth."
Asthma Gene Is Nothing to
Sneeze at
Approximately 5,000 people, many of them
children, will die of asthma this year.
Scientists have long known that allergic reac-
tions to environmental irritants such as dust,
pollen and other allergens, air pollution, and
cigarette smoke trigger asthma attacks. They
have now identified a gene that may con-
tribute to susceptibility to asthma attacks by
telling the body to overproduce a receptor
for immunoglobulin E (IgE), an antibody
involved in allergies.
Researchers led by William Cookson of
John Radcliffe Hospital and Julian Hopkin
of Churchill Hospital, both in Oxford,
England, presented the new research in the
June issue of Nature Genetics. When IgE
binds to a protein receptor in cells lining the
airways of the nose and chest, it sets off a
series of events leading to an allergy attack.
The gene found in the study contains the
information for making part of the IgE
receptor. The researchers found that people
with a particular variant of the gene were
likely to have high levels of IgE in their
blood, an indicator of a tendency to allergy
attacks. The researchers studied 60 families
in which 10 had at least one person who had
inherited both the variant and the allergic
reaction. Of the 12 children who had the
variant, all had allergic reactions, compared
to only 2 ofthe children who did not inherit
the variant.
The researchers stressed that the associa-
tion was found only in a minority of the
families, and that other genes may be impli-
cated in asthma as well. Still, in an article by
the Associated Press, Marshall Plaut, chiefof
the asthma and allergy branch of the
National Institute ofAllergy and Infectious
Diseases, said, "I think they might have at
least a partial answer, and it could be very
important."
Any answers as to how and why people
develop asthma would be good news to the
12 million Americans who suffer from it.
But answers to these questions alone will not
stop the increasing rates of asthma, which
has become a major environmental health
threat, particulary among inner-city children
who are more often exposed to allergens and
air pollution and may be especially sensitive
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to them. Misdiagnosis, mismedication or
lack of treatment, and lack of the means to
remove environmental contibutors to asthma
are common in inner cities. Answers to these
problems are also needed to prevent the
increasing numbers of childhood deaths
from asthma.
Recent studies sponsored by NIH and
the National Center for Health Statistics
(NCHS) show that African-American chil-
dren who live in urban areas are more likely
to develop asthma than white children who
live in the suburbs and more likely to die
from it due to a lack of diagnosis or treat-
ment. In an article in the Washington Post,
epidemiologist Diane Wagener of the
NCHS said, "Deaths due to asthma among
children should not happen, because it's a
preventable situation." Public health officials
say that although genetic research may help
to identify individuals who may be suscepti-
ble to developing asthma, without adequate
prevention and treatment measures the
information has little worth.
Making Headlines on Health
In a recent statement, David Satcher, direc-
tor ofthe Centers for Disease Control, criti-
cized the news media for giving too much
coverage to attention-grabbing health-relat-
ed stories and not enough to less sensation-
al, more substantive issues. In October more
than 400 environmental journalists gathered
in Utah, in part to examine this and other
complaints about their profession.
Speaking at the plenary session of the
1994 Annual Meeting of the Society of
Environmental Journalists, Jim Detjen, an
editor at The Philadelphia Enquirer and the
former president of SEJ, said, "The line is
becoming increasingly blurred between
what is news and what is entertainment."
Detjen cautioned his colleagues that the
current focus on "telling stories" erodes the
credibility of the press and detracts atten-
tion from serious environmental and health
issues. Detjen's observations were echoed by
other members ofthe plenary panel includ-
ing Thomas Winship, chair of the Center
for Foreign Journalists and a former editor
of The Boston Globe; NoelJ. Brown, special
representative of the executive director of
the United Nations Environment
Programme; and F. Sherwood Rowland,
winner of the 1983 Tyler World Prize in
Ecology and Energy for his discoveries of
the depletion of ozone by chlorofluorocar-
bons and the 1987 Award for Creative
Advance in Environmental Science and
Technology. Panelist Erin Hayes, a corre-
spondent for ABC News in Chicago,
advised journalists to avoid the danger of
overdramatizing stories just to make them
sexy enough to get on the air or in the
paper. Said Hayes, "Environmental stories
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need to be told with context and perspective
so people know how it affects their lives."
Journalists at the conference were also
encouraged to lessen their reliance on anec-
dotal evidence and pursue more quotes and
information from science experts. In an
attempt to bring more scientific expertise
into the process ofenvironmental reporting,
scientists working in many of the "hot"
areas ofenvironmental health were brought
to the conference to provide journalists with
briefings on these topics. Researchers
Theodora Colborn, senior scientist at the
World Wildlife Fund, Inc., Earl Gray ofthe
EPA's Health Effects Research Laboratory,
and Stephen Safe, professor oftoxicology at
Texas A&M University, presented a semi-
nar on the role of environmental estrogens
and endocrine disruptors on reproductive
health of humans and animals. A panel
including Robert Alvarez, deputy assistant
secretary for national security and environ-
mental restoration of the Department of
Energy, and Arthur C. Upton, clinical pro-
fessor of pathology and radiology at the
University of New Mexico School of
Medicine, explored issues surrounding
human health and exposure to radiation.
Other sessions discussed topics such as bio-
diversity, a potential ban on chlorine, and
media coverage ofpopulation issues.
EPA Administrator
Carol Browner and Sec-
retary of Energy Hazel
O'Leary were among the
government representa-
tives to address the con-
ference. Commenting on
her agency's unsuccessful
attempt to have Con-
gress pass reforms of the
Safe Drinking Water Act
and Superfund, Browner
said, "What we've run
into is gridlock and
obstructionism that is
truly unprecedented."
Actor and environmen-
talist Robert Redford,
who hosted part of the
conference at his resort
in Sundance, expressed
similar frustration with
Congress for failing to
enact environmental leg-
islation. "[The environ-
ment] is continuously
abused for short-term
and even spurious gain,"
said Redford. "It makes
me sick actually." Red-
ford encouraged journal-
ists to continue to focus
citizens' attention on en-
vironmental and health
issues.
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ER Gene Disruption Is a
Knockout
In the last year scientists have developed a
new tool for research on the effects ofestro-
gen that is a real knockout . . . literally.
Researchers have been able to knock out the
estrogen receptor gene in mice to disrupt the
expression ofestrogen receptor protein in the
hopes that experiments on these animals will
yield new insights into development, fertility,
and the effects ofestrogenic drugs and envi-
ronmental chemicals on the body.
Estrogens bind to the estrogen receptor
protein to activate a variety of physiological
responses including tissue differentiation,
growth, protein synthesis, and hormone
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secretion. In 1990, re-
searchers in the Labor-
atory of Reproductive
and Developmental Tox-
icology at the NIEHS
and the Department of
Pathology at the Uni-
versity ofNorth Carolina
at Chapel Hill were able
to successfully produce a
strain of transgenic mice
(called ERKO for estro-
gen receptor knockout)
that are homozygous for
disrupted function of the
estrogen receptor. The
researchers made two
important discoveries
from this exercise: first,
crosses of heterozygous
strains produced even sex
ratios of homozygous
ER-negative mice, indi-
cating that sex determina-
tion is not influenced by
the absence ofa function-
al estrogen receptor, and
second, this absence is
not necessarily lethal,
although the animals are
infertile.
Scientists are excited
about the possibilities of
using this animal model
to study the role ofestro-
gen in a variety ofdiseases and health effects
on humans. Said Kenneth Korach, chief of
the receptor biology section of the NIEHS
lab, "There is a question of estrogen's exact
role and mode ofaction related to osteoporo-
sis and cardiovascular disease. These ERKO
mice should be a useful experimental model
for answering the question ofwhether estro-
gen plays adirect role."
Because ERKO adult female mice have
undeveloped mammary glands, Korach is
attempting to cross mice with an increased
incidence of mammary cancer with ERKO
mice to test whether the estrogen receptor is
necessary for development of breast cancer.
Studies ofthe reproductive organs offemale
and male ERKO mice may provide informa-
tion on infertility. Female ERKO mice have
dysfunctional ovaries and may be useful for
studying the effects of estrogen therapy.
Studies ofmale ERKO mice, who appear to
have normal male accessory sex organs but
produce less than 10% as much sperm as
normal mice, may be helpful in evaluating
the role of the estrogen receptor in male
reproduction.
Future studies in which ERKO mice are
exposed to environmental estrogenic chemi-
cals and hormonally active drugs such as
tamoxifen and diethystilbestrol may help sci-
entists understand whether these chemicals
operate through the estrogen receptor signal-
ing pathway to cause reproductive tract and
other target tissue cancers in humans.
According to Korach, creation of these ani-
mals and the observation ofnonlethality led
colleagues at the University of Cincinnati
Medical School to the clinical identification
of the first human patient with an estrogen
receptor gene mutation. Said Korach, "Be-
cause both males and females are infertile
due to loss of function mutations of the
estrogen receptor, it brings up the possibility
ofwhether human infertility mayhave a sim-
ilar mutational basis. We are currently
attempting to evaluate some ofthese cases."
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